9WM
CVS icon

9258 Wealth Management’s CVS Health CVS Stock Holding History

9258 Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$739K Sell
11,757
-512
-4% -$29.9K 0.11% 156
2024
Q2 		$725K Sell
12,269
-193
-2% -$12.1K 0.11% 152
2024
Q1 		$994K Sell
12,462
-142
-1% -$10.8K 0.15% 123
2023
Q4 		$995K Sell
12,604
-431
-3% -$30.7K 0.18% 114
2023
Q3 		$910K Buy
13,035
+984
+8% +$69.7K 0.18% 111
2023
Q2 		$833K Buy
12,051
+63
+0.5% +$4.48K 0.16% 123
2023
Q1 		$891K Sell
11,988
-1,856
-13% -$156K 0.18% 105
2022
Q4 		$1.29M Buy
13,844
+1,477
+12% +$143K 0.28% 78
2022
Q3 		$1.18M Sell
12,367
-1,031
-8% -$102K 0.3% 74
2022
Q2 		$1.24M Buy
13,398
+187
+1% +$18.3K 0.32% 77
2022
Q1 		$1.34M Sell
13,211
-293
-2% -$30.8K 0.31% 70
2021
Q4 		$1.39M Buy
13,504
+238
+2% +$22K 0.32% 63
2021
Q3 		$1.13M Sell
13,266
-3,155
-19% -$264K 0.3% 74
2021
Q2 		$1.37M Sell
16,421
-863
-5% -$70.7K 0.37% 54
2021
Q1 		$1.3M Buy
17,284
+470
+3% +$34.2K 0.39% 54
2020
Q4 		$1.15M Buy
16,814
+641
+4% +$41.7K 0.37% 55
2020
Q3 		$907K Buy
16,173
+1,010
+7% +$62.8K 0.34% 69
2020
Q2 		$985K Buy
15,163
+1,438
+10% +$90.6K 0.4% 63
2020
Q1 		$872K Buy
13,725
+442
+3% +$29.5K 0.38% 66
2019
Q4 		$987K Buy
13,283
+1,812
+16% +$127K 0.36% 75
2019
Q3 		$723K Sell
11,471
-77
-0.7% -$4.56K 0.56% 60
2019
Q2 		$629K Buy
11,548
+336
+3% +$18.1K 0.51% 66
2019
Q1 		$605K Buy
11,212
+1,421
+15% +$87.7K 0.51% 67
2018
Q4 		$642K Buy
+9,791
New +$731K 0.62% 55

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

9258 Wealth Management's CVS Position: Q3 2024 in Review

9258 Wealth Management reduced its CVS Health (CVS) stake by 4.2% in Q3 2024, selling an estimated $29.9K and leaving 11,757 shares worth $739K. The position accounts for 0.11% of the portfolio, ranked #156.

9258 Wealth Management first reported a position in CVS in Q4 2018 and has held it in 24 quarters since. The position peaked at $1.39M in Q4 2021. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • 9258 Wealth Management held 11,757 shares of CVS Health worth $739K as of Q3 2024.
  • 9258 Wealth Management sold 512 CVS Health shares in Q3 2024, an estimated $29.9K.
  • CVS Health made up 0.11% of 9258 Wealth Management's portfolio in Q3 2024, its #156 holding.
  • 9258 Wealth Management first reported a position in CVS Health in Q4 2018 and has held it in 24 quarters since.
  • 9258 Wealth Management's CVS Health position peaked at $1.39M in Q4 2021.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.